2024-03-29T14:31:39Z
https://tsukuba.repo.nii.ac.jp/oai
oai:tsukuba.repo.nii.ac.jp:00056041
2023-10-02T00:56:49Z
2780:2206
3:62:5591:6135
Pembrolizumab versus chemotherapy in recurrent, advanced urothelial cancer in Japanese patients : a subgroup analysis of the phase 3 KEYNOTE-045 trial
西山, 博之
ニシヤマ, ヒロユキ
NISHIYAMA, Hiroyuki
Yamamoto, Yoshiaki
Sassa, Naoto
Nishimura, Kazuo
Fujimoto, Kiyohide
Fukasawa, Satoshi
Yokoyama, Minato
Enokida, Hideki
Takahashi, Kenichi
Tanaka, Yoshinobu
Imai, Kentaro
Shimamoto, Takashi
Perini, Rodolfo
Frenkl, Tara
Bajorin, Dean
Bellmunt, Joaquim
open access
(c) The Author(s) 2019
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Springer
2019-01
eng
journal article
VoR
http://hdl.handle.net/2241/00161444
https://tsukuba.repo.nii.ac.jp/records/56041
31729625
https://doi.org/10.1007/s10147-019-01545-4
1341-9625
AA11086579
International Journal of Clinical Oncology
25
1
165
174
https://tsukuba.repo.nii.ac.jp/record/56041/files/IJCO_25-1-165.pdf
application/pdf
656.0 kB
2020-09-24